With respect to the effect of ibuprofen on cancer cell stemness properties, we found that the immunocytochemical staining of SOX2 and OCT4 stemness markers decreases in the ibuprofen-treated groups versus DMSO controls (Fig. 2h, i). The gene discussed is POU5F1; the disease is cancer.